FindLaw | Legal Professionals | Students | Business | Public | News   E-mail@Justice.com | MY FindLaw 
FindLaw Class Action Center
  Class Action Center | Class Action News | Class Action Notices | Class Action Settlements | Recalls | Legal Research & Practice Ad Info
Home
Accutane
Acetaminophen
Ambien
Aredia
Avandia
Baycol
Benzene
Beryllium
Bextra
Celebrex
Celexa
Cialis
Crestor
Darvon / Darvocet
Depo-Provera
Diclofenac
Drug-Coated Stents
Duragesic Patch
Effexor
Ephedra
Evista
Fen-Phen
Fluvoxamine
Food Poisoning
Fosamax
Gleevec
Guidant Defibrillator
Ketek
Lasik Eye Surgery
Lead Poisoning
Levitra
Lexapro
Light Cigarettes
Medtronic Defibrillator
Meridia
Mesothelioma - Asbestos
Mirapex
MoisturePlus Lens Solution
Motor Vehicle Defects
Neurontin
Ortho Evra Patch
Paxil
Perchlorate
Pergolide (Permax)
Popcorn Lung Illness
Prempro
Promethazine HCl
Prozac
ReNu with MoistureLoc
Risperdal
Seroquel
Serzone
Silicosis & Silica
Spinach Recall and E. coli
Symbyax
Tamiflu
Teflon
Tequin
Trasylol
Triaminic Vapor Patch
Viagra
Vioxx
Welding Rods
Zoloft
Zometa
Zyprexa
Recalls & Safety Alerts
Consumer Products
Food and Drugs
Motor Vehicles
News
Notices
Settlements
Legal Research
FindLaw Class Action and Mass Tort Center: Recalls: Food, Drugs and Medical Devices: Maxair Inhaler Recalled

NEWS: U.S. Department of Health andHuman Services


FDA posts press releases and other notices of recalls from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.


Maxair Inhaler Recalled

NEWS RELEASE



Contact:  John Cornwell
          651/733-7698
          Fax: 651/575-0616
                     

For Immediate Release

Maxair Inhaler Recalled

ST. PAUL, Minn.--(BW HealthWire)--May 8, 2002--3M Pharmaceuticals Division today announced a voluntary recall of the prescription medication Maxair Inhaler (pirbuterol acetate inhalation aerosol). This is a press-and-breathe metered-dose inhaler. The lot numbers are 000644, 000756, 000947, 001009, 001110, 001111, 010025, 010195, 010283, 010413, 010414, 010482, 010580, 010708, 010709, 011210. The recall has been issued as a precaution to address the remote possibility that a Maxair press-and-breathe aerosol inhaler may stick intermittently and patients may not receive the expected puff of medication.

This recall does not affect Maxair Autohaler (pirbuterol acetate inhalation aerosol), a breath-actuated metered-dose inhaler.

Patients currently using the Maxair press-and-breathe inhaler are advised to return the product to their pharmacy. 3M is unable to offer patients an exact replacement unit at this time, as the Maxair press-and-breathe inhaler is currently unavailable. Patients can obtain the same medication in a different delivery device. 3M will provide Maxair autohaler (pirbuterol acetate inhalation aerosol), a breath-actuated inhaler (200 mcg pirbuterol/ inhalation), free of charge in exchange for the Maxair press-and-breathe inhaler (200 mcg pirbuterol/inhalation). A physician prescription will be required to obtain a Maxair autohaler or any other inhaler replacement.

The recall is being conducted with the knowledge of the U. S. Food and Drug Administration.

3M Pharmaceuticals has provided a dedicated toll-free number to respond to questions from patients and physicians. The toll-free number is 1-800-390-1132. This line is available seven days a week, 8:30 a.m. to 5 p.m. EDT.




  FindLaw.com
Advertising Info · Add URL · Help · Comments Jobs@FindLaw · Site Map
Company | Privacy Policy | Disclaimer Copyright © 1994-2012 FindLaw